Anti-Human ANGPT2 & VEGFA Recombinant Antibody(Vanucizumab)
-
产品编号
YR1341
-
别名
科研级 Vanucizumab ( 伐努赛珠单抗 ), Anti-ANGPT2 & VEGFA Recombinant Antibody, Research Grade Vanucizumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1341 |
| Alias | 科研级 Vanucizumab ( 伐努赛珠单抗 ), Anti-ANGPT2 & VEGFA Recombinant Antibody, Research Grade Vanucizumab |
| Size | 1mg, 5mg |
| Molecular Name | Vanucizumab |
| CAS Number | 1448221-05-3 |
| Target | ANGPT2 & VEGFA[Homo sapiens], |
| Antibody Isotype | VH-C Kappa-CH2-CH3_V Lambda-CH1_H-GAMMA-1_L Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Vanucizumab (INN, development code RG7221) is an experimental humanized monoclonal antibody designed for the treatment of cancer. |
| Application | WB, FCM, IP, ELISA, Neut, FuncS, IF |
| Remarks | This product is for research use only. |
0